Shi Zhe, Jifang Weng, Xiaochong Fan, Qing-Fang Zhu, Emily Robb, A. Moriarty, M. Wick, Jiang Yueheng, Ling Zhang, D. Xing, Wang Yaolin
{"title":"摘要1056:在KRas G12C突变的患者源性异种移植肿瘤模型中,D-1553作为单一药物和联合靶向治疗药物的体内抗肿瘤活性","authors":"Shi Zhe, Jifang Weng, Xiaochong Fan, Qing-Fang Zhu, Emily Robb, A. Moriarty, M. Wick, Jiang Yueheng, Ling Zhang, D. Xing, Wang Yaolin","doi":"10.1158/1538-7445.AM2021-1056","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12258,"journal":{"name":"Experimental and Molecular Therapeutics","volume":"11 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Abstract 1056: Potentin vivoanti-tumor activity of D-1553 as a single agent and in combination with targeted therapeutics in a broad spectrum of patient-derived xenograft tumor models with KRas G12C mutation\",\"authors\":\"Shi Zhe, Jifang Weng, Xiaochong Fan, Qing-Fang Zhu, Emily Robb, A. Moriarty, M. Wick, Jiang Yueheng, Ling Zhang, D. Xing, Wang Yaolin\",\"doi\":\"10.1158/1538-7445.AM2021-1056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12258,\"journal\":{\"name\":\"Experimental and Molecular Therapeutics\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and Molecular Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.AM2021-1056\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Molecular Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.AM2021-1056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract 1056: Potentin vivoanti-tumor activity of D-1553 as a single agent and in combination with targeted therapeutics in a broad spectrum of patient-derived xenograft tumor models with KRas G12C mutation